ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Passive Transdermal Drug Delivery Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-22O9317
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Passive Transdermal Drug Delivery Market Insights and Forecast to 2028
BUY CHAPTERS

Global Passive Transdermal Drug Delivery Market Research Report 2025

Code: QYRE-Auto-22O9317
Report
August 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
3M
Actavis
Bayer
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline PLC
Johnson& Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson& Johnson (Janssen Pharmaceuticals Inc.)

Passive Transdermal Drug Delivery Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Passive Transdermal Drug Delivery Market

Passive Transdermal Drug Delivery Market

The global market for Passive Transdermal Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Passive Transdermal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Passive Transdermal Drug Delivery.
The Passive Transdermal Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Passive Transdermal Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Passive Transdermal Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Passive Transdermal Drug Delivery Market Report

Report Metric Details
Report Name Passive Transdermal Drug Delivery Market
CAGR 5%
Segment by Type
Segment by Application
  • Clinic
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company 3M, Actavis, Inc., Bayer AG, Boehringer Ingelheim GmbH, Corium International, Inc., Echo Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson (Janssen Pharmaceuticals Inc.), Mylan N.V., Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Passive Transdermal Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Passive Transdermal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Passive Transdermal Drug Delivery Market report?

Ans: The main players in the Passive Transdermal Drug Delivery Market are 3M, Actavis, Inc., Bayer AG, Boehringer Ingelheim GmbH, Corium International, Inc., Echo Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson (Janssen Pharmaceuticals Inc.), Mylan N.V., Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp.

What are the Application segmentation covered in the Passive Transdermal Drug Delivery Market report?

Ans: The Applications covered in the Passive Transdermal Drug Delivery Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Passive Transdermal Drug Delivery Market report?

Ans: The Types covered in the Passive Transdermal Drug Delivery Market report are Microfluidics, Smart Pill Technology (SPT)

Recommended Reports

Drug Delivery Systems

Microneedle & Needle-Free

Topical & Intranasal

1 Passive Transdermal Drug Delivery Market Overview
1.1 Product Definition
1.2 Passive Transdermal Drug Delivery by Type
1.2.1 Global Passive Transdermal Drug Delivery Market Value Comparison by Type (2024 VS 2031)
1.2.2 Microfluidics
1.2.3 Smart Pill Technology (SPT)
1.3 Passive Transdermal Drug Delivery by Application
1.3.1 Global Passive Transdermal Drug Delivery Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Passive Transdermal Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Passive Transdermal Drug Delivery Revenue 2020-2031
1.4.2 Global Passive Transdermal Drug Delivery Sales 2020-2031
1.4.3 Global Passive Transdermal Drug Delivery Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Passive Transdermal Drug Delivery Market Competition by Manufacturers
2.1 Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturers (2020-2025)
2.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Passive Transdermal Drug Delivery Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Passive Transdermal Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Passive Transdermal Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Passive Transdermal Drug Delivery, Product Type & Application
2.7 Global Key Manufacturers of Passive Transdermal Drug Delivery, Date of Enter into This Industry
2.8 Global Passive Transdermal Drug Delivery Market Competitive Situation and Trends
2.8.1 Global Passive Transdermal Drug Delivery Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Passive Transdermal Drug Delivery Players Market Share by Revenue
2.8.3 Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Passive Transdermal Drug Delivery Market Scenario by Region
3.1 Global Passive Transdermal Drug Delivery Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Passive Transdermal Drug Delivery Sales by Region: 2020-2031
3.2.1 Global Passive Transdermal Drug Delivery Sales by Region: 2020-2025
3.2.2 Global Passive Transdermal Drug Delivery Sales by Region: 2026-2031
3.3 Global Passive Transdermal Drug Delivery Revenue by Region: 2020-2031
3.3.1 Global Passive Transdermal Drug Delivery Revenue by Region: 2020-2025
3.3.2 Global Passive Transdermal Drug Delivery Revenue by Region: 2026-2031
3.4 North America Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.4.1 North America Passive Transdermal Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Passive Transdermal Drug Delivery Sales by Country (2020-2031)
3.4.3 North America Passive Transdermal Drug Delivery Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Passive Transdermal Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Passive Transdermal Drug Delivery Sales by Country (2020-2031)
3.5.3 Europe Passive Transdermal Drug Delivery Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Passive Transdermal Drug Delivery Market Facts & Figures by Region
3.6.1 Asia Pacific Passive Transdermal Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2020-2031)
3.6.3 Asia Pacific Passive Transdermal Drug Delivery Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Passive Transdermal Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Passive Transdermal Drug Delivery Sales by Country (2020-2031)
3.7.3 Latin America Passive Transdermal Drug Delivery Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Passive Transdermal Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Passive Transdermal Drug Delivery Sales by Country (2020-2031)
3.8.3 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Passive Transdermal Drug Delivery Sales by Type (2020-2031)
4.1.1 Global Passive Transdermal Drug Delivery Sales by Type (2020-2025)
4.1.2 Global Passive Transdermal Drug Delivery Sales by Type (2026-2031)
4.1.3 Global Passive Transdermal Drug Delivery Sales Market Share by Type (2020-2031)
4.2 Global Passive Transdermal Drug Delivery Revenue by Type (2020-2031)
4.2.1 Global Passive Transdermal Drug Delivery Revenue by Type (2020-2025)
4.2.2 Global Passive Transdermal Drug Delivery Revenue by Type (2026-2031)
4.2.3 Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2020-2031)
4.3 Global Passive Transdermal Drug Delivery Price by Type (2020-2031)
5 Segment by Application
5.1 Global Passive Transdermal Drug Delivery Sales by Application (2020-2031)
5.1.1 Global Passive Transdermal Drug Delivery Sales by Application (2020-2025)
5.1.2 Global Passive Transdermal Drug Delivery Sales by Application (2026-2031)
5.1.3 Global Passive Transdermal Drug Delivery Sales Market Share by Application (2020-2031)
5.2 Global Passive Transdermal Drug Delivery Revenue by Application (2020-2031)
5.2.1 Global Passive Transdermal Drug Delivery Revenue by Application (2020-2025)
5.2.2 Global Passive Transdermal Drug Delivery Revenue by Application (2026-2031)
5.2.3 Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2020-2031)
5.3 Global Passive Transdermal Drug Delivery Price by Application (2020-2031)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Company Information
6.1.2 3M Description and Business Overview
6.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.1.4 3M Passive Transdermal Drug Delivery Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Actavis, Inc.
6.2.1 Actavis, Inc. Company Information
6.2.2 Actavis, Inc. Description and Business Overview
6.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.2.5 Actavis, Inc. Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Company Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer AG Passive Transdermal Drug Delivery Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 Boehringer Ingelheim GmbH
6.4.1 Boehringer Ingelheim GmbH Company Information
6.4.2 Boehringer Ingelheim GmbH Description and Business Overview
6.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Portfolio
6.4.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.5 Corium International, Inc.
6.5.1 Corium International, Inc. Company Information
6.5.2 Corium International, Inc. Description and Business Overview
6.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.5.5 Corium International, Inc. Recent Developments/Updates
6.6 Echo Therapeutics, Inc.
6.6.1 Echo Therapeutics, Inc. Company Information
6.6.2 Echo Therapeutics, Inc. Description and Business Overview
6.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.6.5 Echo Therapeutics, Inc. Recent Developments/Updates
6.7 GlaxoSmithKline plc
6.7.1 GlaxoSmithKline plc Company Information
6.7.2 GlaxoSmithKline plc Description and Business Overview
6.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Portfolio
6.7.5 GlaxoSmithKline plc Recent Developments/Updates
6.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
6.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Information
6.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
6.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Portfolio
6.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
6.9 Mylan N.V.
6.9.1 Mylan N.V. Company Information
6.9.2 Mylan N.V. Description and Business Overview
6.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mylan N.V. Passive Transdermal Drug Delivery Product Portfolio
6.9.5 Mylan N.V. Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Company Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis AG Passive Transdermal Drug Delivery Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 Noven Pharmaceuticals, Inc.
6.11.1 Noven Pharmaceuticals, Inc. Company Information
6.11.2 Noven Pharmaceuticals, Inc. Description and Business Overview
6.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.11.5 Noven Pharmaceuticals, Inc. Recent Developments/Updates
6.12 Transdermal Corp.
6.12.1 Transdermal Corp. Company Information
6.12.2 Transdermal Corp. Description and Business Overview
6.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Product Portfolio
6.12.5 Transdermal Corp. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Passive Transdermal Drug Delivery Industry Chain Analysis
7.2 Passive Transdermal Drug Delivery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Passive Transdermal Drug Delivery Production Mode & Process Analysis
7.4 Passive Transdermal Drug Delivery Sales and Marketing
7.4.1 Passive Transdermal Drug Delivery Sales Channels
7.4.2 Passive Transdermal Drug Delivery Distributors
7.5 Passive Transdermal Drug Delivery Customer Analysis
8 Passive Transdermal Drug Delivery Market Dynamics
8.1 Passive Transdermal Drug Delivery Industry Trends
8.2 Passive Transdermal Drug Delivery Market Drivers
8.3 Passive Transdermal Drug Delivery Market Challenges
8.4 Passive Transdermal Drug Delivery Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
3M
Actavis
Bayer
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline PLC
Johnson& Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson& Johnson (Janssen Pharmaceuticals Inc.)
List of Tables
 Table 1. Global Passive Transdermal Drug Delivery Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Passive Transdermal Drug Delivery Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Passive Transdermal Drug Delivery Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Passive Transdermal Drug Delivery Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Passive Transdermal Drug Delivery Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Passive Transdermal Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Passive Transdermal Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Passive Transdermal Drug Delivery, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Passive Transdermal Drug Delivery, Product Type & Application
 Table 12. Global Key Manufacturers of Passive Transdermal Drug Delivery, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Passive Transdermal Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Passive Transdermal Drug Delivery as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Passive Transdermal Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Passive Transdermal Drug Delivery Sales by Region (2020-2025) & (K Units)
 Table 18. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2020-2025)
 Table 19. Global Passive Transdermal Drug Delivery Sales by Region (2026-2031) & (K Units)
 Table 20. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2026-2031)
 Table 21. Global Passive Transdermal Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2020-2025)
 Table 23. Global Passive Transdermal Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2026-2031)
 Table 25. North America Passive Transdermal Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Passive Transdermal Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 27. North America Passive Transdermal Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 28. North America Passive Transdermal Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Passive Transdermal Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Passive Transdermal Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Passive Transdermal Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Passive Transdermal Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Passive Transdermal Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Passive Transdermal Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Passive Transdermal Drug Delivery Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Passive Transdermal Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Passive Transdermal Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Passive Transdermal Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Passive Transdermal Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Passive Transdermal Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Passive Transdermal Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Passive Transdermal Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Passive Transdermal Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Passive Transdermal Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Passive Transdermal Drug Delivery Sales (K Units) by Type (2020-2025)
 Table 51. Global Passive Transdermal Drug Delivery Sales (K Units) by Type (2026-2031)
 Table 52. Global Passive Transdermal Drug Delivery Sales Market Share by Type (2020-2025)
 Table 53. Global Passive Transdermal Drug Delivery Sales Market Share by Type (2026-2031)
 Table 54. Global Passive Transdermal Drug Delivery Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Passive Transdermal Drug Delivery Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2020-2025)
 Table 57. Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2026-2031)
 Table 58. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Passive Transdermal Drug Delivery Sales (K Units) by Application (2020-2025)
 Table 61. Global Passive Transdermal Drug Delivery Sales (K Units) by Application (2026-2031)
 Table 62. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2020-2025)
 Table 63. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2026-2031)
 Table 64. Global Passive Transdermal Drug Delivery Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Passive Transdermal Drug Delivery Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2020-2025)
 Table 67. Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2026-2031)
 Table 68. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Application (2026-2031)
 Table 70. 3M Company Information
 Table 71. 3M Description and Business Overview
 Table 72. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. 3M Passive Transdermal Drug Delivery Product
 Table 74. 3M Recent Developments/Updates
 Table 75. Actavis, Inc. Company Information
 Table 76. Actavis, Inc. Description and Business Overview
 Table 77. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Actavis, Inc. Passive Transdermal Drug Delivery Product
 Table 79. Actavis, Inc. Recent Developments/Updates
 Table 80. Bayer AG Company Information
 Table 81. Bayer AG Description and Business Overview
 Table 82. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Bayer AG Passive Transdermal Drug Delivery Product
 Table 84. Bayer AG Recent Developments/Updates
 Table 85. Boehringer Ingelheim GmbH Company Information
 Table 86. Boehringer Ingelheim GmbH Description and Business Overview
 Table 87. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product
 Table 89. Boehringer Ingelheim GmbH Recent Developments/Updates
 Table 90. Corium International, Inc. Company Information
 Table 91. Corium International, Inc. Description and Business Overview
 Table 92. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Corium International, Inc. Passive Transdermal Drug Delivery Product
 Table 94. Corium International, Inc. Recent Developments/Updates
 Table 95. Echo Therapeutics, Inc. Company Information
 Table 96. Echo Therapeutics, Inc. Description and Business Overview
 Table 97. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product
 Table 99. Echo Therapeutics, Inc. Recent Developments/Updates
 Table 100. GlaxoSmithKline plc Company Information
 Table 101. GlaxoSmithKline plc Description and Business Overview
 Table 102. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product
 Table 104. GlaxoSmithKline plc Recent Developments/Updates
 Table 105. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Information
 Table 106. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
 Table 107. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product
 Table 109. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
 Table 110. Mylan N.V. Company Information
 Table 111. Mylan N.V. Description and Business Overview
 Table 112. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Mylan N.V. Passive Transdermal Drug Delivery Product
 Table 114. Mylan N.V. Recent Developments/Updates
 Table 115. Novartis AG Company Information
 Table 116. Novartis AG Description and Business Overview
 Table 117. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Novartis AG Passive Transdermal Drug Delivery Product
 Table 119. Novartis AG Recent Developments/Updates
 Table 120. Noven Pharmaceuticals, Inc. Company Information
 Table 121. Noven Pharmaceuticals, Inc. Description and Business Overview
 Table 122. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product
 Table 124. Noven Pharmaceuticals, Inc. Recent Developments/Updates
 Table 125. Transdermal Corp. Company Information
 Table 126. Transdermal Corp. Description and Business Overview
 Table 127. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Transdermal Corp. Passive Transdermal Drug Delivery Product
 Table 129. Transdermal Corp. Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Passive Transdermal Drug Delivery Distributors List
 Table 133. Passive Transdermal Drug Delivery Customers List
 Table 134. Passive Transdermal Drug Delivery Market Trends
 Table 135. Passive Transdermal Drug Delivery Market Drivers
 Table 136. Passive Transdermal Drug Delivery Market Challenges
 Table 137. Passive Transdermal Drug Delivery Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Passive Transdermal Drug Delivery
 Figure 2. Global Passive Transdermal Drug Delivery Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Passive Transdermal Drug Delivery Market Share by Type: 2024 & 2031
 Figure 4. Microfluidics Product Picture
 Figure 5. Smart Pill Technology (SPT) Product Picture
 Figure 6. Global Passive Transdermal Drug Delivery Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Passive Transdermal Drug Delivery Market Share by Application: 2024 & 2031
 Figure 8. Clinic
 Figure 9. Hospital
 Figure 10. Others
 Figure 11. Global Passive Transdermal Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Passive Transdermal Drug Delivery Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Passive Transdermal Drug Delivery Sales (2020-2031) & (K Units)
 Figure 14. Global Passive Transdermal Drug Delivery Average Price (USD/Unit) & (2020-2031)
 Figure 15. Passive Transdermal Drug Delivery Report Years Considered
 Figure 16. Passive Transdermal Drug Delivery Sales Share by Manufacturers in 2024
 Figure 17. Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Passive Transdermal Drug Delivery Players: Market Share by Revenue in Passive Transdermal Drug Delivery in 2024
 Figure 19. Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Passive Transdermal Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Passive Transdermal Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 22. North America Passive Transdermal Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Passive Transdermal Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 26. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Passive Transdermal Drug Delivery Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Passive Transdermal Drug Delivery Revenue Market Share by Region (2020-2031)
 Figure 34. China Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Passive Transdermal Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Passive Transdermal Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Passive Transdermal Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Passive Transdermal Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Passive Transdermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Passive Transdermal Drug Delivery by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Passive Transdermal Drug Delivery by Type (2020-2031)
 Figure 56. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Passive Transdermal Drug Delivery by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Passive Transdermal Drug Delivery by Application (2020-2031)
 Figure 59. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Application (2020-2031)
 Figure 60. Passive Transdermal Drug Delivery Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Active Transdermal Drug Delivery Device Market Research Report 2024
Global Drug Transdermal Diffusion Tester Market Research Report 2024
Drug Transdermal Diffusion Apparatus Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dermatological OTC Drugs Market Research Report 2024
Microneedle Transdermal Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alternative Drug Delivery Systems Market Research Report 2024
Global Advanced Targeted Drug Delivery Market Research Report 2025
Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Invasive Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injectable Drug Delivery Formulation Market Research Report 2024
Global Intranasal Drug Delivery Market Research Report 2024
Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Dermatological Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Disposable Closed Drug Transfer Systems Market Research Report 2025
Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Wearable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024
Global Absorbable Pain Relievers for External Use Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions